{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:12:19Z","timestamp":1791825139592,"version":"4.3.4"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["redjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.ijrobp.2018.04.011","type":"journal-article","created":{"date-parts":[[2018,4,12]],"date-time":"2018-04-12T01:58:50Z","timestamp":1523498330000},"page":"900-909","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Baseline Albumin-Bilirubin (ALBI) Score in Western Patients With Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy (SBRT)"],"prefix":"10.1016","volume":"101","author":[{"given":"Louise J.","family":"Murray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna","family":"Sykes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Brierley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca K.S.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolie","family":"Ringash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Craig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0825-9792","authenticated-orcid":false,"given":"Michael","family":"Velec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Lindsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer J.","family":"Knox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura A.","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2018.04.011_bib1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.37549\/ARO1028","article-title":"Stereotactic body radiation therapy (SBRT) for early-stage primary liver cancer (HCC)","volume":"4","author":"Schulz","year":"2013","journal-title":"Appl Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2018.04.011_bib2","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1055\/s-2008-1040325","article-title":"Assessment of prognosis of cirrhosis","volume":"28","author":"Durand","year":"2008","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.ijrobp.2018.04.011_bib3","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1200\/JCO.2014.59.0521","article-title":"Addressing the interplay of liver disease and hepatocellular carcinoma on patient survival: The ALBI scoring model","volume":"33","author":"Knox","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.04.011_bib4","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","article-title":"Assessment of liver function in patients with hepatocellular carcinoma: A new evidence-based approach-the ALBI grade","volume":"33","author":"Johnson","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.04.011_bib5","first-page":"1","article-title":"Surgery and portal hypertension","volume":"1","author":"Child","year":"1964","journal-title":"Major Probl Clin Surg"},{"key":"10.1016\/j.ijrobp.2018.04.011_bib6","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0168-8278(00)00011-8","article-title":"A prognostic model for predicting survival in cirrhosis with ascites","volume":"34","author":"Fernandez-Esparrach","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.ijrobp.2018.04.011_bib7","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1053\/he.2000.5852","article-title":"A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts","volume":"31","author":"Malinchoc","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.ijrobp.2018.04.011_bib8","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1200\/JCO.2012.44.1659","article-title":"Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma","volume":"31","author":"Bujold","year":"2013","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.ijrobp.2018.04.011_bib9","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.ijrobp.2017.01.221","article-title":"Predictors of liver toxicity following stereotactic body radiation therapy for hepatocellular carcinoma","volume":"97","author":"Velec","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.04.011_bib10","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1080\/02841860600936369","article-title":"Individualized image guided iso-NTCP based liver cancer SBRT","volume":"45","author":"Dawson","year":"2006","journal-title":"Acta Oncol"},{"issue":"3 Suppl","key":"10.1016\/j.ijrobp.2018.04.011_bib11","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.ijrobp.2009.06.092","article-title":"Radiation-associated liver injury","volume":"76","author":"Pan","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.04.011_bib12","series-title":"Applied Linear Regression Models","author":"Kunter","year":"2004"},{"key":"10.1016\/j.ijrobp.2018.04.011_bib13","doi-asserted-by":"crossref","first-page":"A460","DOI":"10.1136\/gutjnl-2015-309861.1008","article-title":"PTH-120 Albi score predicts survival independently of hepatic venous pressure gradient (HVPG) and indocyanine green (ICG) clearance in HCC patients undergoing resection","volume":"64","author":"Onali","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.ijrobp.2018.04.011_bib14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cca.2016.08.005","article-title":"Application of the albumin-bilirubin grade for predicting prognosis after curative resection of patients with early-stage hepatocellular carcinoma","volume":"462","author":"Ma","year":"2016","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ijrobp.2018.04.011_bib15","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jvir.2016.03.005","article-title":"Independent analysis of albumin-bilirubin grade in a 765-patient cohort treated with transarterial locoregional therapy for hepatocellular carcinoma","volume":"27","author":"Hickey","year":"2016","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.ijrobp.2018.04.011_bib16","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/bjs.10095","article-title":"Albumin-bilirubin versus Child-Pugh score as a predictor of outcome after liver resection for hepatocellular carcinoma","volume":"103","author":"Wang","year":"2016","journal-title":"Br J Surg"},{"key":"10.1016\/j.ijrobp.2018.04.011_bib17","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/hepr.12796","article-title":"Prognostic value of the albumin-bilirubin grade in patients with hepatocellular carcinoma: Validation in a Chinese cohort","volume":"47","author":"Li","year":"2017","journal-title":"Hepatol Res"},{"key":"10.1016\/j.ijrobp.2018.04.011_bib18","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/jgh.13250","article-title":"Usefulness of albumin-bilirubin grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma","volume":"31","author":"Hiraoka","year":"2016","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.ijrobp.2018.04.011_bib19","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/jgh.13291","article-title":"Integration of albumin-bilirubin (ALBI) score into Barcelona Clinic Liver Cancer (BCLC) system for hepatocellular carcinoma","volume":"31","author":"Chan","year":"2016","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.ijrobp.2018.04.011_bib20","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.prro.2016.10.003","article-title":"Assessment of hepatic function decline after stereotactic body radiation therapy for primary liver cancer","volume":"7","author":"Toesca","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2018.04.011_bib21","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ijrobp.2017.04.036","article-title":"Comparison between Child-Turcotte-Pugh and albumin-bilirubin scores in assessing the prognosis of hepatocellular carcinoma after stereotactic ablative radiation therapy","volume":"99","author":"Lo","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.04.011_bib22","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/0360-3016(93)90398-F","article-title":"Use of Veff and iso-NTCP in the implementation of dose escalation protocols","volume":"27","author":"Ten Haken","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.04.011_bib23","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.ijrobp.2004.11.013","article-title":"Use of principal component analysis to evaluate the partial organ tolerance of normal tissues to radiation","volume":"62","author":"Dawson","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.04.011_bib24","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/hep.510290145","article-title":"Natural history of untreated nonsurgical hepatocellular carcinoma: Rationale for the design and evaluation of therapeutic trials","volume":"29","author":"Llovet","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.ijrobp.2018.04.011_bib25","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.ijrobp.2004.08.028","article-title":"Local radiotherapy for patients with unresectable hepatocellular carcinoma","volume":"61","author":"Park","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030161830662X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030161830662X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T01:56:03Z","timestamp":1693619763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S036030161830662X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S036030161830662X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2018.04.011","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Baseline Albumin-Bilirubin (ALBI) Score in Western Patients With Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy (SBRT)","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2018.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}